• At Pharmaceutical Specialties, Inc. patient care comes first.
services. cystic fibrosis therapies
Recently developed therapies and specialized care have enabled people with cystic fibrosis to gain greater control over their disease. So, children and adults are not only living longer, but also living a better quality of life. While cystic fibrosis is not preventable, there are methods of treatment that can ease the symptoms or slow the progress of the disease so the patient's quality of life is improved.

Pharmaceutical Specialties, Inc. is committed to carrying a variety of medications and devices used in patient care and providing a higher quality of life. We are proud to be distributors of a variety of medications and supplies, including: Trio® Electronic Nebulizer, LC Plus®, and Altera.




founder. respiratory disease network


A founding member of the Respiratory Disease Network,

Pharmaceutical Specialties, Inc. is the sole provider of the Trio® and accompanying medicines for patients in Alabama, Georgia, North Carolina, South Carolina, Virginia, Washington DC and for those with traditional Florida Medicaid.

Respiratory Disease Network

http://www.respiratorydiseasenetwork.com/images/RDN%20Logo%20without%20Number%20copy.jpg

why. choose us
We also offer patients a variety of other medications specially designed for
cystic fibrosis patients, including:
  • Cayston®
  • Kalydeco
  • Pulmozyme®
  • TOBI®
  • Trio®  Electronic Nebulizer
  • SourceCF®  Softgel High Potency Adult Multivitamins softgels, chewables, and drops
  • Ultresa™
  • Xopenex® 
  • Hypertonic Saline 3%, 5%, 7%, 10% including Hyper Sal by PARI
  • Colistimethate
  • Pancreatic enzymes
  • Antibiotics
  • Many more
For more information on our cystic fibrosis treatment options, contact us today.

*Disclaimer: The eFlow® nebulizer has not undergone human clinical studies to determine its safety or efficacy and has not been approved by the FDA for use with tobramycin in the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis. Compounded prescriptions are not evaluated by the FDA for safety or efficacy.


the latest. news



Pharmaceutical Specialties, Inc. is a proud founding sponsor of the
 Journey to Independence CF Program offered by Children’s Healthcare of Atlanta.